Riccardo Canevari

Chief Executive Officer at RADIOPHARM THERANOSTICS LIMITED

Net worth: 222 944 $ as of 2026-07-30

Health Technology

Health Services

Profile

Riccardo Canevari is currently Chief Executive Officer, MD & Director at Radiopharm Theranostics Ltd. since 2021.
Formerly, Mr. Canevari was Senior Vice President at Novartis Oncology, Inc. and Chief Commercial Officer at Advanced Accelerator Applications SA.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
RADIOPHARM THERANOSTICS LIMITED 0.58%	2026-03-17	22,679,986 ( 0.58% )	222 944 $	2026-07-30

Riccardo Canevari active positions

Companies	Position	Start
RADIOPHARM THERANOSTICS LIMITED	Chief Executive Officer	2021-09-12

All active positions of Riccardo Canevari

Former positions of Riccardo Canevari

Companies	Position	End
Novartis Oncology, Inc. Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Corporate Officer/Principal	-
ADVANCED ACCELERATOR APPLICATION SA(ADR)	Corporate Officer/Principal	-

See the detail of Riccardo Canevari's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Riccardo Canevari's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Novartis Oncology, Inc. Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
Advanced Accelerator Applications SA Advanced Accelerator Applications SA Pharmaceuticals: MajorHealth Technology Develops and produces nuclear medicine and radioligand therapies	Health Technology
Radiopharm Theranostics Ltd. Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services	Health Services